WANBURY240.65

Wanbury Limited

· Pharma & Health
₹ CrorePeersAHCLANUHPHRBAJAJHCARETHEMISMEDZIMLABLINCOLNSIGACHIVALIANTLABMcap ₹789 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
WANBURY
FY25
AHCL
FY26
ANUHPHR
FY26
BAJAJHCARE
FY26
Peer
Median
Valuation — at last close
P/E25.82×2.91×22.37×66.57×22.37× +15%
P/B13.30×0.37×2.61×2.09×2.09× +535%
EV/EBITDA12.55×2.82×14.03×12.52×12.52× +0%
Market Cap₹789 Cr₹94.5 Cr₹919 Cr₹1,116 Cr₹919 Cr -14%
Growth
Revenue CAGR 3Y5.46%-3.18%-3.18% +272%
Revenue CAGR 5Y10.29%
Net Income CAGR 3Y-27.91%-28.44%-28.44% +2%
Revenue YoY (latest Q)24.47%3.93%11.28%7.60% +222%
Net Income YoY (latest Q)1200.41%37.63%15.75%26.69% +4398%
Profitability
EBITDA Margin12.73%27.63%8.00%17.15%17.15% -26%
Net Income Margin5.09%16.92%5.32%2.58%5.32% -4%
Return on Common Equity51.51%11.19%11.65%2.96%11.19% +360%
Return on Capital Employed26.33%17.26%14.21%12.80%14.21% +85%
Return on Assets7.38%7.78%7.36%1.71%7.36% +0%
Credit & Quality
Total Debt/Equity2.92×0.17×0.00×0.44×0.17× +1618%
Interest Coverage1.71×12.30×106.58×3.48×12.30× -86%
Scale — latest FY
Revenue / Total Income₹600 Cr₹172 Cr₹772 Cr₹611 Cr₹611 Cr -2%
Net Income₹30.5 Cr₹29.1 Cr₹41 Cr₹15.8 Cr₹29.1 Cr +5%
Total Assets₹414 Cr₹374 Cr₹557 Cr₹923 Cr₹557 Cr -26%
EPS₹9.32₹6.11₹4.1₹4.98₹4.98 +87%
Book Value per Share₹18.09₹47.94₹35.14₹158.34₹47.94 -62%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.